Following the review of the age-appropriateness of formulations of medicines for children on the EMLc, the Expert Committee recommended: - the addition of morphine injection 1 mg/mL and 2 mg/mL in 2 mL ampoule to the EMLc; - the addition of morphine oral liquid 5 mg/5 mL to the EMLc; - the addition of morphine solid oral dosage form (slow-release) 5 mg to the EMLc; - the deletion of morphine granules (slow-release) 200 mg and morphine solid oral dosage form 200 mg (slow release) from the EMLc; - to replace the strength range for morphine granules and solid oral dosage form (slow release) with specific strengths on the EML and EMLc; - to modify the formulation descriptions of morphine injection to better describe the available dosage forms.